Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Non-Hodgkin lymphoma, unspecified (C85.9)
C85.9
Non-Hodgkin lymphoma, unspecified
Sub-codes (10)
- C85.90 Non-Hodgkin lymphoma, unspecified, unspecified site
- C85.91 Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck
- C85.92 Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes
- C85.93 Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes
- C85.94 Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb
- C85.95 Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb
- C85.96 Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes
- C85.97 Non-Hodgkin lymphoma, unspecified, spleen
- C85.98 Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites
- C85.99 Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
Related indications (MeSH) (3)
Lymphoma1111 drugs (436 approved, 675 experimental)
A general term for various neoplastic diseases of the lymphoid tissue.
Lymphoma, B-Cell334 drugs (123 approved, 211 experimental)
A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
Lymphoma, Non-Hodgkin886 drugs (274 approved, 612 experimental)
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.